Evexia Lifecare (BSE 524444)₹1.41−2.76%Trading - Chemicals
In the Sep 2026 quarter (consolidated), Evexia Lifecare reported sales of ₹25 Cr, down 2.8% from Sep 2025, and net profit of ₹0.24 Cr, down 36.8% year on year. For the year to Mar 2026, sales were ₹110 Cr and net profit ₹2.01 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.74 | 24.71 | 21.22 | 26.70 | 21.71 | 23.59 | 22.08 | 25.72 | 25.26 | 36.81 | 30.90 | 25.00 |
| Expenses | 6.75 | 21.64 | 20.90 | 25.59 | 21.51 | 22.25 | 21.00 | 25.59 | 24.95 | 35.66 | 30.31 | 25.05 |
| Operating Profit | −0.02 | 3.07 | 0.31 | 1.10 | 0.18 | 1.33 | 1.09 | 0.11 | 0.26 | 1.11 | 0.55 | −0.08 |
| OPM % | −0.2% | 12.4% | 1.4% | 4.1% | 0.8% | 5.6% | 4.9% | 0.4% | 1.0% | 3.0% | 1.7% | −0.3% |
| Other Income | 0.00 | 0.87 | 0.14 | 0.00 | 0.11 | 0.00 | 0.00 | 0.44 | 0.27 | 0.11 | 0.16 | 0.81 |
| Interest | 0.00 | 0.48 | 0.00 | 0.04 | 0.00 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Depreciation | 0.06 | 0.14 | 0.09 | 0.10 | 0.10 | 0.45 | 0.20 | 0.02 | 0.11 | 0.29 | 0.10 | 0.28 |
| Profit before tax | −0.06 | 3.27 | 0.32 | 0.92 | 0.15 | 0.44 | 0.85 | 0.49 | 0.38 | 0.89 | 0.56 | 0.36 |
| Tax % | −28.5% | 16.8% | 24.3% | 0.0% | 25.0% | 31.1% | 25.6% | 28.0% | 25.6% | 13.3% | 26.3% | 35.2% |
| Net Profit | −0.06 | 2.74 | 0.25 | 0.95 | 0.13 | 0.32 | 0.64 | 0.38 | 0.30 | 0.79 | 0.43 | 0.24 |
| EPS (Rs) | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.99 | 178 | 73.99 | 105 | 99.96 | 107 | 75.95 | 69.95 | 55.99 | 86.92 | 110 | 118 |
| Expenses | 33.97 | 176 | 73.89 | 106 | 107 | 179 | 72.91 | 68.89 | 53.95 | 84.84 | 107 | 116 |
| Operating Profit | 0.00 | 1.01 | 0.00 | −1.01 | −6.01 | −72.22 | 2.01 | 1.01 | 2.01 | 2.01 | 3.01 | 1.84 |
| OPM % | −0.3% | 0.7% | −0.5% | −0.8% | −6.0% | −68.0% | 3.2% | 0.8% | 3.5% | 1.9% | 2.6% | 1.6% |
| Other Income | 1.01 | 0.00 | 1.01 | 3.01 | 12.04 | 74.20 | 0.00 | 2.01 | 1.01 | 0.00 | 0.00 | 1.35 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.06 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.78 |
| Profit before tax | 0.00 | 0.99 | 0.99 | 1.99 | 4.99 | 1.99 | 1.99 | 1.99 | 1.99 | 0.99 | 1.99 | 2.19 |
| Tax % | 41.0% | 32.0% | 33.0% | 30.0% | 29.0% | 33.0% | 60.0% | 56.0% | 28.0% | 55.0% | 26.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.00 | 1.01 | 0.00 | 2.01 | 3.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 2.01 | 1.76 |
| EPS (Rs) | 0.00 | 0.02 | 0.00 | 0.02 | 0.05 | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 45.84 | 61.77 | 61.78 | 61.80 | 61.82 | 61.80 | 61.75 | 61.79 | 65.98 | 70.94 | 188 | 187 |
| Reserves | 19.05 | 3.01 | 4.01 | 11.03 | 13.04 | 16.05 | 18.07 | 19.05 | 24.10 | 59.22 | 273 | 248 |
| Borrowings | 4.99 | 10.96 | 5.98 | 5.97 | 3.99 | 6.97 | 6.97 | 5.98 | 705 | 685 | 385 | 2.99 |
| Other Liabilities | 3.98 | 34.98 | 147 | 128 | 146 | 139 | 55.85 | 40.88 | 52.25 | 67.32 | 75.36 | 435 |
| Total Liabilities | 73.86 | 112 | 218 | 208 | 224 | 224 | 142 | 127 | 848 | 882 | 920 | 872 |
| Fixed Assets | 2.01 | 2.01 | 2.01 | 9.01 | 9.01 | 9.01 | 9.01 | 9.01 | 11.01 | 11.01 | 50.01 | 18.01 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.01 | 1.01 | 0.99 | 0.00 | 0.00 | 0.00 | 0.99 | 1.01 | 704 | 724 | 718 | 711 |
| Other Assets | 67.84 | 109 | 215 | 199 | 216 | 215 | 132 | 115 | 132 | 148 | 154 | 144 |
| Inventories | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 3.01 | 1.01 | 2.01 | 1.01 | 3.01 | 3.01 |
| Trade receivables | 1.99 | 21.99 | 139 | 34.95 | 56.99 | 67.97 | 45.99 | 14.98 | 30.97 | 43.96 | 92.92 | 115 |
| Cash & equivalents | 0.99 | 2.01 | 1.01 | 0.99 | 0.99 | 0.00 | 1.01 | 1.99 | 0.00 | 0.99 | 4.99 | 1.99 |
| Total Assets | 73.86 | 112 | 218 | 208 | 224 | 224 | 142 | 127 | 848 | 882 | 920 | 872 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.01 | 11.03 | −116 | −12.04 | — | −3.01 | 2.01 | −6.02 | −3.01 | 17.06 | −2.01 | −23.08 |
| Cash from investing activity | 0.00 | 1.99 | 0.99 | −5.99 | — | 0.99 | −2.01 | 7.99 | −697 | −16.99 | −18.01 | 53.01 |
| Cash from financing activity | −4.01 | −11.99 | 113 | 18.02 | — | 2.01 | 1.01 | −1.01 | 699 | 0.99 | 19.99 | −27.99 |
| Net cash flow | 0.99 | 1.01 | −1.99 | 0.00 | — | 0.00 | 0.00 | 1.01 | −0.99 | 0.00 | 0.00 | 1.99 |
| Capex | 0.23 | 0.13 | 0.09 | 6.58 | 0.03 | 0.61 | 0.18 | 2.48 | 2.44 | 0.25 | 0.00 | 3.22 |
| Free cash flow | 4.01 | 11.04 | −116 | −18.06 | — | −3.01 | 2.01 | −8.03 | −6.02 | 17.06 | −2.01 | −27.08 |
| CFO / OP % | −8,199.9% | −9,863.9% | −9,144.9% | 3,357.1% | — | 52.1% | −3.0% | −151.9% | −184.0% | 910.1% | −193.9% | −817.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 983 | 237 | 286 | 174 | 197 | 249 | 156 | 73 | 164 | 282 | 392 | 379 |
| Inventory days | 197 | 5 | 2 | 3 | 3 | 2 | 12 | 7 | 11 | 8 | 12 | 9 |
| Days payable | 186 | 383 | 72 | 66 | 157 | 171 | 113 | 123 | 185 | 194 | 279 | 196 |
| Cash conversion cycle | 993 | −142 | 215 | 109 | 42 | 80 | 54 | −44 | −11 | 95 | 123 | 191 |
| Working capital days | −1,578 | 248 | 250 | 278 | 134 | 245 | 192 | 175 | 207 | 343 | 143 | 194 |
| ROCE % | — | 0.0% | 2.0% | 1.0% | 3.0% | 6.1% | 2.0% | 3.0% | 0.0% | 0.0% | 0.0% | 0.0% |
For the Sep 2026 quarter, Evexia Lifecare reported sales of ₹25 Cr, down 2.8% year on year and net profit of ₹0.24 Cr, down 36.8% year on year. The operating margin was −0.3%.
Evexia Lifecare's sales for the year to Mar 2026 were ₹110 Cr; over the last twelve months they were ₹118 Cr.
Net profit for the year to Mar 2026 was ₹2.01 Cr, and ₹1.76 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.00.
Evexia Lifecare reported borrowings of ₹2.99 Cr at Mar 2026, against cash and equivalents of ₹1.99 Cr.
Cash from operations was −₹23.08 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹27.08 Cr.